A
$ Value
$0
Shares
12,846
Price
$0
Filed
Jun 4
Insider
Name
Keswani Sanjay Chandru
Title
Chief Medical Officer
CIK
0001818524
Roles
Officer
Transaction Details
Transaction Date
2025-06-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
12,846
Footnotes
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. | The Restricted Stock Units will vest annually at 25% of the units vesting on each of June 2, 2026, June 2, 2027, June 2, 2028, and June 2, 2029. | Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on June 2, 2026 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter.
Filing Info
Keswani Sanjay Chandru's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-13 | NBIX | A | $0 |
| 2026-02-13 | NBIX | A | $0 |
| 2025-06-02 | NBIX | A | $0 |
| 2025-06-02 | NBIX | A | $0 |
Other Insiders at NBIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GORMAN KEVIN CHARLES | — | — | 2026-02-13 |
|
Lippoldt Darin
Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gano Kyle
Chief Executive Officer
|
— | — | 2026-02-13 |
|
BENEVICH ERIC
Chief Commercial Officer
|
— | — | 2026-02-13 |
|
ABERNETHY MATT
Chief Financial Officer
|
— | — | 2026-03-04 |
|
Cooke Julie
Chief Human Resources Officer
|
— | — | 2026-02-13 |
|
Keswani Sanjay Chandru
Chief Medical Officer
|
— | — | 2026-02-13 |
|
Onyia Jude
Chief Scientific Officer
|
— | — | 2026-02-20 |
|
Boyer David W.
Chief Corp. Affairs Officer
|
— | — | 2026-02-13 |
|
Delaet Ingrid
Chief Regulatory Officer
|
— | — | 2026-02-13 |